In the specialized field of biochemical research, the CH-275 peptide has garnered significant attention as a by R Mansi·2004·Cited by 4—An efficient synthetic procedure for the preparation of the somatostatin analogueCH-275and its conjugate DTPAGlu-Gly-CH-275, bearing the chelating agent Read more highly specific tool for studying cellular signaling pathways. As someone deeply interested in the nuances of peptide chemistry and receptor interaction, I have spent considerable time reviewing the literature regarding this somatostatin analog. My focus here is to provide a comprehensive overview of what makes this compound unique in laboratory settings, strictly for informational purposes regarding its role in academic and biochemical inquiry.
Understanding the Nature of CH-275
At its core, CH 275 is a peptide analog of somatostatin, designed with high structural precision. It is widely recognized in scientific literature as a cyclic peptide agonist of somatostatin receptor 1 (SST1). Unlike broader analogs that might interact with multiple receptor subtypes, CH-275 is prized for its selectivity.
When conducting research, purity is paramount. CH 275 is a high-purity biochemical reagent often sourced by laboratories to ensure that experimental results—such as those involving signaling pathways—remain consistent and reproducible. The compound, identified by CAS number 174688-78-9, is frequently util Design, synthesis and structure of an amphipathic peptide ized in studies that require a potent and selective interaction with the SST1 receptor, often exhibiting a Ki of approximatel Drug design at peptide receptors: somatostatin y 52 nM.
Technical Specifications and Receptor Selectivity
The utility of this peptide lies in its selectiv CH 275 is a cyclic peptide agonist of somatostatin receptor 1(SST1; IC50 = 30.9 nM for the human receptor). It is selective for SST1 over SST2, SST3, SST e behavior. In various displacement experiments, it has demonstrated a clear preference for SST1 over other receptors like SST2, SST3, and SST4. This selectivity is a critical factor for researchers aiming to isolate the physiological effects mediated specifically through the SST1 receptor.
In terms of peptide synthesis, the complexity of creating cyclic structures like CH-275 requires advanced methodologies. The synthesis must account for the stability of the cyclic backbone to maintain its biological activity. Furthermore, researche CH 275 is a peptide analog of somatostatinand binds preferably to somatostatin receptor 1 (sst1) with a Ki of 52 nM . CH 275 acts as a potent and selective rs have explored CH-275 peptide derivatives, such as those conjugated with chelating agents like DTPA, to expand the potential applications of this mo by R Mansi·2004·Cited by 4—An efficient synthetic procedure for the preparation of the somatostatin analogueCH-275and its conjugate DTPAGlu-Gly-CH-275, bearing the chelating agent Read more lecule in targeted imaging or other specialized biochemical assays.
Broader Context in Peptide Research
The study of peptides is a vast field, encompassing everything from simple chains to complex, macrocyclic structures. While CH-275 is a specialized tool, it sits within a broader framework of research involving:
* Signaling Pathway Modulation: Beyond its primary role, researchers have investigated how specialized molecules can prevent adrenergic regulation of pacemaker channels, providing insights into complex cellular feedback loops.
* Structural Diversity: Whether discussing a peptide-based biostimulant used in agricultural science or a highly specific reagent like CH-275, the underlying chemistry of amino acid sequencing remains the foundation of discovery.
* Analytical Methods: As detailed in many a chapter on proteomics, the characterization of such molecules requires rigorous analytical techniques to verify higher-order structures and purity levels.
Observations on Laboratory Use
For those involved in laboratory work, the distinction between different analogs is vital. When comparing CH-275 to other somatostatin analogs, the primar Peptide Oriented Peptides (POPs), innovatively developed by CH Biotech,is a pep- tide-based biostimulantwith potential to address extreme climate problems Read more y differentiator is its specific affinity. Whether one is investigating the channel dynamics of a cell or the regulatory effects on adenylyl cyclase, the use of a well-characterized agonist is indispensable.
It is fascinating to see how the evolution of peptides continues to influence our understanding of molecular biology. From the initial synthesis to the final application in a controlled environment, every step—including the careful handling of CH-275—is a testament to the precision required in modern biochemica by TJ Wang·2004·Cited by 2071—The natriureticpeptidesare counterregulatory hormones involved in volume homeostasis and cardiovascular remodeling. The prognostic significance of plasma l research.
***
*Disclaimer: This article is for educational and informational purposes only. The substances mentioned are for laboratory research use only and are not intended for human consumption, medical diagnosis, or prescription use.*